PMID: 41715239

Efficacy and safety of orforglipron, an oral small-molecule GLP-1 receptor agonist, on cardiometabolic outcomes: a meta-analysis and systematic review.

Alper Adir, Peleg Gal, Fagin Adina, Shah Priyansh, Chowdhury Ishmum, Gonzales Antony, Faillace Robert

Cardiovascular diabetology. Endocrinology reports · 2026

Vol. 12, Issue 1, pp. 9

View on PubMedDOI

This entry links to third-party literature. For research use only.

For research use only. This index links to third-party literature. Nothing here constitutes medical advice.